ARTICLES BY LIISA VEXLER
-
FDA Issues Statement On Prescription Opioid Abuse4/7/2014
In a statement made April 3rd, the U.S. Food and Drug Administration (FDA) commissioner, Margaret A. Hamburg, discussed her agency’s efforts to address the public health crisis resulting from improper use, abuse, addiction, and overdose of prescription opioid products.
-
New System Allows Safe Disposal Of Unused Prescription Medications4/7/2014
Pharmaceutical company, Mallinckrodt Pharmaceuticals and biotechnology company, Verde Environmental Technologies have partnered to create a solution for the responsible disposal of unused personal prescription medications, especially opioids.
-
Bipolar Disorder Benefits from Stem Cell Research3/26/2014
University of Michigan scientists have managed to create brain cells from embryonic-like stem cells that they have grown from individuals with bipolar disorder, and these brain cells are providing insight into some of the mysteries of the psychiatric condition.
-
Lawmakers Request Explanation From Gilead Sciences for High Cost of New Hep C Treatment3/26/2014
Solvaldi (sofosbuvir) was introduced by Gilead Sciences in December as a breakthrough treatment for Hepatitis C with the capability to cure more individuals in a shorter period of time. However, U.S. legislators and insurance companies are expressing concern over the cost of treatment pegged at $84,000, a cost most companies and government programs will not cover.
-
Just Under $2 million Awarded To Pediatric Praziquantel Consortium3/25/2014
A research grant of $1.86 million was awarded to the Pediatric Praziquantel Consortium by Japanese Global Health Innovative Technology (GHIT) Fund. The funds granted are to support development and registration of a new formulation of pediatric praziquantel to treat schistosomiasis in a population which includes infants, toddlers and preschoolers.
-
Ligand Pharmaceuticals Earns Million Dollar Milestone Payment3/19/2014
Ligand Pharmaceuticals Incorporated announced that it has received a million dollar milestone payment as a result of FDA approval of Merck's anti-fungal NOXAFIL injection. This new intravenous formulation of the product uses Ligand’s Captisol under commercial supply agreement.
-
ORBCOMM Expands M2M Offering With Euroscan Cold Chain Acquisition3/17/2014
The acquisition of Euroscan Holdings, B.V. (Euroscan) by ORBCOMM is now complete. Euroscan is a global market leader in the supply of recording systems for the transportation of goods requiring special temperature controlled environments.
-
Aramex To Launch Biocare: The New Cold Supply Chain Solution3/17/2014
Biocare, a new service by Aramex, which operates as part of the cold supply chain category, will now be available in prominent markets for the company.
-
New Fungicide Captan Gold 80 WDG Launched By MANA3/17/2014
Raleigh, the N.C. based MANA company, has developed and launched a new fungicide known as Captan Gold 80 WDG.
-
Hopes For HIV Vaccine After Recent Scientific Study3/17/2014
New research to look at the structure of HIV has revealed the possibility of developing a vaccine for the disease. During a detailed investigation into the structure of the disease, at atomic level, details of HIV’s ‘envelope’ protein have been found.